These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32759194)

  • 1. Neutral lipid-storage disease with myopathy and Jordan anomaly.
    Zuccarino R; Anderson DM; Holman C; Feely S; Gutmann L; Gutmann L
    Neurology; 2020 Sep; 95(13):599-600. PubMed ID: 32759194
    [No Abstract]   [Full Text] [Related]  

  • 2. Jordan's anomaly in a case of Chanarin-Dorfman syndrome.
    Pike GN; Jones S; Coassin S; Kronenberg F; Will A
    Br J Haematol; 2011 Nov; 155(4):412. PubMed ID: 21689090
    [No Abstract]   [Full Text] [Related]  

  • 3. MiRNAs as biomarkers of phenotype in neutral lipid storage disease with myopathy.
    Pegoraro V; Missaglia S; Marozzo R; Tavian D; Angelini C
    Muscle Nerve; 2020 Feb; 61(2):253-257. PubMed ID: 31729045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel PNPLA2 mutation causes neutral lipid storage disease with myopathy (NLSDM) presenting muscular dystrophic features with lipid storage and rimmed vacuoles.
    Chen J; Hong D; Wang Z; Yuan Y
    Clin Neuropathol; 2010; 29(6):351-6. PubMed ID: 21073837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mutation in PNPLA2 causes neutral lipid storage disease with myopathy and triglyceride deposit cardiomyovasculopathy: a case report and literature review.
    Kaneko K; Kuroda H; Izumi R; Tateyama M; Kato M; Sugimura K; Sakata Y; Ikeda Y; Hirano K; Aoki M
    Neuromuscul Disord; 2014 Jul; 24(7):634-41. PubMed ID: 24836204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mutation in PNPLA2 leading to neutral lipid storage disease with myopathy.
    Ash DB; Papadimitriou D; Hays AP; Dimauro S; Hirano M
    Arch Neurol; 2012 Sep; 69(9):1190-2. PubMed ID: 22964912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutral lipid storage disease with myopathy and dropped head syndrome. Report of a new variant susceptible of treatment with late diagnosis.
    Garcia MA; Rojas JA; Millán SP; Flórez AA
    J Clin Neurosci; 2018 Dec; 58():207-209. PubMed ID: 30352762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A myopathy with unusual features caused by PNPLA2 gene mutations.
    Pennisi EM; Missaglia S; Dimauro S; Bernardi C; Akman HO; Tavian D
    Muscle Nerve; 2015 Apr; 51(4):609-13. PubMed ID: 25287355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific myocardial disease caused by multisystemic triglyceride storage in Jordans' anomaly.
    Takahira T; Utsunomiya T; Ishijima M; Mori H; Yano K; Nunobiki T; Eto H
    Am Heart J; 1993 Oct; 126(4):995-7. PubMed ID: 8213462
    [No Abstract]   [Full Text] [Related]  

  • 10. Patients with neutral lipid storage disease with myopathy (NLSDM) in Southwestern China.
    Tan J; Yang H; Fan J; Fan Y; Xiao F
    Clin Neurol Neurosurg; 2018 May; 168():102-107. PubMed ID: 29539587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutral lipid storage disease with myopathy with a novel homozygous PNPLA2 variant.
    Yamada K; Yaguchi H; Abe M; Ishikawa K; Tanaka D; Oshima Y; Kudo A; Uwatoko H; Shirai S; Takahashi-Iwata I; Matsushima M; Nishino I; Yabe I
    Clin Neurol Neurosurg; 2023 May; 228():107670. PubMed ID: 36996668
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of bezafibrate treatment in a patient and a carrier with mutations in the PNPLA2 gene, causing neutral lipid storage disease with myopathy.
    van de Weijer T; Havekes B; Bilet L; Hoeks J; Sparks L; Bosma M; Paglialunga S; Jorgensen J; Janssen MC; Schaart G; Sauerwein H; Smeets JL; Wildberger J; Zechner R; Schrauwen-Hinderling VB; Hesselink MK; Schrauwen P
    Circ Res; 2013 Mar; 112(5):e51-4. PubMed ID: 23449549
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical findings and autophagic pathology in neutral lipid storage disease with myopathy.
    Hong D; Zheng J; Xin L; Xiang Y; Luan X; Cao L; Cong L; Fang P; Zhang J
    Clin Neuropathol; 2019; 38(4):157-167. PubMed ID: 30738494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutral Lipid Storage Disease Associated with the PNPLA2 Gene: Case Report and Literature Review.
    Samukawa M; Nakamura N; Hirano M; Morikawa M; Sakata H; Nishino I; Izumi R; Suzuki N; Kuroda H; Shiga K; Saigoh K; Aoki M; Kusunoki S
    Eur Neurol; 2020; 83(3):317-322. PubMed ID: 32564019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclinical myopathy in a child with neutral lipid storage disease and mutations in the PNPLA2 gene.
    Fiorillo C; Brisca G; Cassandrini D; Scapolan S; Astrea G; Valle M; Scuderi F; Trucco F; Natali A; Magnano G; Gazzerro E; Minetti C; Arca M; Santorelli FM; Bruno C
    Biochem Biophys Res Commun; 2013 Jan; 430(1):241-4. PubMed ID: 23146629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late onset of neutral lipid storage disease due to a rare PNPLA2 mutation in a patient with myopathy and cardiomyopathy.
    Tian Y; Wang S; Wang F; Yi L; Dong M; Huang X
    Chin Med J (Engl); 2022 Oct; 135(19):2389-2391. PubMed ID: 36535014
    [No Abstract]   [Full Text] [Related]  

  • 17. [Unusual phenotype of myopathy associated with a new PNPLA2 mutation].
    Jousserand G; Streichenberger N; Petiot P
    Med Sci (Paris); 2016 Nov; 32 Hors série n°2():10-11. PubMed ID: 27869069
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel PNPLA2 gene mutations in Chinese Han patients causing neutral lipid storage disease with myopathy.
    Lin P; Li W; Wen B; Zhao Y; Fenster DS; Wang Y; Gong Y; Yan C
    J Hum Genet; 2012 Oct; 57(10):679-81. PubMed ID: 22832386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late onset of neutral lipid storage disease due to novel PNPLA2 mutations causing total loss of lipase activity in a patient with myopathy and slight cardiac involvement.
    Missaglia S; Maggi L; Mora M; Gibertini S; Blasevich F; Agostoni P; Moro L; Cassandrini D; Santorelli FM; Gerevini S; Tavian D
    Neuromuscul Disord; 2017 May; 27(5):481-486. PubMed ID: 28258942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutral lipid-storage disease with myopathy and extended phenotype with novel PNPLA2 mutation.
    Massa R; Pozzessere S; Rastelli E; Serra L; Terracciano C; Gibellini M; Bozzali M; Arca M
    Muscle Nerve; 2016 Apr; 53(4):644-8. PubMed ID: 26600210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.